Autori: Lertratanakul Apinya
| Naslov | Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo Or Adalimumab: Results from a Phase 3 Trial (Meeting Abstract) |
| Autori | Gossec Laure Damjanov Nemanja S Tsuji Shigeyoshi Lertratanakul Apinya Lippe Ralph Patel Janki Zueger Patrick De Vlam K |
| Info | ANNALS OF THE RHEUMATIC DISEASES, (2022), vol. 81 br. , Suppl. 1, str. 1569-1570 |
| Projekat | AbbVie Inc. |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Trial (Meeting Abstract) |
| Autori | Gossec Laure Damjanov Nemanja S Tsuji Shigeyoshi Lertratanakul Apinya Lippe Ralph Patel Jayeshkumar Zueger Patrick De Vlam Kurt |
| Info | ARTHRITIS & RHEUMATOLOGY, (2021), vol. 73 br. , Suppl. 9, str. 3986-3989 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
